NCT00344227View on ClinicalTrials.gov

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

April 30, 2007

Conditions

Neovascular Age-Related Macular Degeneration

Interventions

DRUG

Lucentis (Ranibizumab)

Trial Locations (1)

33136

Bascom Palmer Eye Institute, Miami

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Miami

OTHER